REPORT ID 2294

Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Report 2017

Publish Date
8-Dec-17
Pages
119
Format
Electronic (PDF)

In this report, the global Hypoxia Inducible Factor 1 Alpha Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Hypoxia Inducible Factor 1 Alpha Inhibitor for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Hypoxia Inducible Factor 1 Alpha Inhibitor market competition by top manufacturers/players, with Hypoxia Inducible Factor 1 Alpha Inhibitor sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Aileron Therapeutics, Inc.
    CASI Pharmaceuticals Inc.
    Cerulean Pharma, Inc.
    F. Hoffmann-La Roche Ltd.
    InterMed Discovery GmbH
    OncoImmune, Inc.
    Peloton Therapeutics, Inc.
    RXi Pharmaceuticals Corporation
    Sorrento Therapeutics, Inc.
    Transcriptogen Ltd
    Vascular Biogenics Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BC-001
    CASI-2ME2
    CRLX-101
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Solid Tumor
    Acute Myelocytic Leukemia
    Colorectal Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Report 2017
1 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Overview
    1.1 Product Overview and Scope of Hypoxia Inducible Factor 1 Alpha Inhibitor
    1.2 Classification of Hypoxia Inducible Factor 1 Alpha Inhibitor by Product Category
        1.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 BC-001
        1.2.4 CASI-2ME2
        1.2.5 CRLX-101
        1.2.6 Others
    1.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market by Application/End Users
        1.3.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Solid Tumor
        1.3.3 Acute Myelocytic Leukemia
        1.3.4 Colorectal Cancer
        1.3.5 Others
    1.4 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market by Region
        1.4.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2012-2022)
        1.4.3 China Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2012-2022)
        1.4.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2012-2022)
        1.4.5 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2012-2022)
        1.4.7 India Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Hypoxia Inducible Factor 1 Alpha Inhibitor (2012-2022)
        1.5.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Growth Rate (2012-2022)
        1.5.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2012-2022)

2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Competition by Players/Suppliers, Type and Application
     2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Competition by Players/Suppliers
        2.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume and Value) by Type
        2.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Market Share by Type (2012-2017)
        2.2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Market Share by Type (2012-2017)
    2.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume and Value) by Region
        2.3.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Market Share by Region (2012-2017)
        2.3.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Market Share by Region (2012-2017)
    2.4 Global Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume) by Application

3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume, Value and Sales Price)
    3.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Value (2012-2017)
        3.1.1 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Growth Rate (2012-2017)
        3.1.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2012-2017)
        3.1.3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Price Trend (2012-2017)
    3.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Players
    3.3 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Type
    3.4 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Application

4 China Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume, Value and Sales Price)
    4.1 China Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Value (2012-2017)
        4.1.1 China Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Growth Rate (2012-2017)
        4.1.2 China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2012-2017)
        4.1.3 China Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Price Trend (2012-2017)
    4.2 China Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Players
    4.3 China Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Type
    4.4 China Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Application

5 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume, Value and Sales Price)
    5.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Value (2012-2017)
        5.1.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Growth Rate (2012-2017)
        5.1.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Price Trend (2012-2017)
    5.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Players
    5.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Type
    5.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Application

6 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume, Value and Sales Price)
    6.1 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Value (2012-2017)
        6.1.1 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Growth Rate (2012-2017)
        6.1.2 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Price Trend (2012-2017)
    6.2 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Players
    6.3 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Type
    6.4 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Application

7 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume, Value and Sales Price)
    7.1 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Value (2012-2017)
        7.1.1 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Price Trend (2012-2017)
    7.2 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Players
    7.3 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Type
    7.4 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Application

8 India Hypoxia Inducible Factor 1 Alpha Inhibitor (Volume, Value and Sales Price)
    8.1 India Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Value (2012-2017)
        8.1.1 India Hypoxia Inducible Factor 1 Alpha Inhibitor Sales and Growth Rate (2012-2017)
        8.1.2 India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate (2012-2017)
        8.1.3 India Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Price Trend (2012-2017)
    8.2 India Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Players
    8.3 India Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Type
    8.4 India Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Market Share by Application

9 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Players/Suppliers Profiles and Sales Data
    9.1 Aileron Therapeutics, Inc.
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 CASI Pharmaceuticals Inc.
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Cerulean Pharma, Inc.
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 F. Hoffmann-La Roche Ltd.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 InterMed Discovery GmbH
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 OncoImmune, Inc.
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Peloton Therapeutics, Inc.
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 RXi Pharmaceuticals Corporation
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Sorrento Therapeutics, Inc.
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Transcriptogen Ltd
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Vascular Biogenics Ltd.

10 Hypoxia Inducible Factor 1 Alpha Inhibitor Maufacturing Cost Analysis
    10.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
    10.3 Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Hypoxia Inducible Factor 1 Alpha Inhibitor Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Forecast (2017-2022)
    14.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price and Trend Forecast (2017-2022)
    14.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Hypoxia Inducible Factor 1 Alph